PeptideStack
5.2kquestions
20kanswers
220users

If I reconstitute a 60 mg vial with 2.5 mL of bacteriostatic water, what concentration do I end up with?

Asked 5 Dec 2024Modified 16 months agoViewed 29k times
31

What I am working with: 60 mg · 2.5 mL · bacteriostatic water.

The units are where I keep going wrong, so please be explicit about them.

I have sanity-checked the order of magnitude and it seems right, which is not the same as being right.

Where is my error, and what is the correct working?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
bacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

149 questions
shareeditfollowflag
HP
askedhana_petrikova10k145 Dec 2024
3Are you asking about the arithmetic or the technique? Both are answerable, separately. – sian_llewellyn 9 months ago
4Voting to keep this open — it is more specific than it first looks. – pk_curve 25 days ago
add a comment

5 Answers

Sorted by votes
40

60 ÷ 2.5 = 24 mg/mL. Concentration is vial content divided by diluent volume, so 60 mg of peptide in 2.5 mL of bacteriostatic water gives 24 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.24 mg — 240 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.

Stated carefully, the answer depends on what you want your measurement resolution to be, and that is a real trade-off rather than a preference. More diluent gives you more syringe marks per dose and therefore less rounding error; it also gives you a larger volume to keep cold and a longer period over which the solution has to remain within specification.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.

Reading a lyophilised cake

AppearanceInterpretationAction
Intact opaque puck, proud of baseCycle ran correctlyProceed
Slumped to one sideShipped before fully dry, or vibrationUsually usable; note it
Glassy translucent filmCollapse above glass transitionTest before use
Melt-back ring at stopperThermal excursion in transitTest before use
No visible cake at allVery low fill, or nothing thereWeigh it; query the supplier

The underlying point is that a 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.

Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.

One limitation: technique reduces risk, it does not remove it.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
PH
answeredper_haugen13k1711 Jan 2025
2Small correction: the units in the third paragraph should be micrograms, not milligrams. – Dr_Bram_Verhoeven 10 months ago
3This should be linked from the help pages. – swab_and_wait 39 days ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
26

This is not exotic. It is just the difference between doing it deliberately and doing it approximately.

Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.

The part that matters: if the material arrived warm and it was lyophilised, test it and proceed on the result.

The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
BB
answeredbac_or_bust33k13722 Jan 2025
22

Gentle swirling dissolves a lyophilised cake far better than vigorous shaking, which causes aeration and aggregation.

Number of stopper piercings matters less than the gauge doing the piercing.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.

Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

edited 10 Feb 2025 by tabular_nums — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
TN
answeredtabular_nums71k482 Feb 2025
17

Sodium chloride 0.9 per cent as a diluent is not a neutral substitution. Ionic strength affects peptide solubility and aggregation propensity.

Do not use the same needle to pierce the stopper and to administer.

I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.

Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.

shareimprove this answerflag
TN
answeredtabular_nums71k4813 Feb 2025
16

Reconstitution is the step where most hands-on errors enter the system, which is why spending time on technique here pays off more than anywhere else.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.

The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale against the barrel rather than against your assumption.

shareimprove this answerflag
ED
answerede_dziedzic51k14727 Mar 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.